药明康德(02359)今日盘中大涨5.79%，引起了市场的广泛关注。
消息面上，开源证券表示，“药明系”三家公司均对2026年增长给出积极展望：其中，药明康德持续经营业务收入指引同比增长18–22%，资本支出(CAPEX)计划进一步提升至65–75亿元。整体来看，这反映了CXO（医药外包）行业在订单、产能与需求端共振下的景气延续性进一步强化，增强了投资者对公司未来业绩的信心，从而推动股价上行。
药明康德(02359)今日盘中大涨5.79%，引起了市场的广泛关注。
消息面上，开源证券表示，“药明系”三家公司均对2026年增长给出积极展望：其中，药明康德持续经营业务收入指引同比增长18–22%，资本支出(CAPEX)计划进一步提升至65–75亿元。整体来看，这反映了CXO（医药外包）行业在订单、产能与需求端共振下的景气延续性进一步强化，增强了投资者对公司未来业绩的信心，从而推动股价上行。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.